The role of cold ischemia time and hypothermic perfusion in predicting early hepatocellular carcinoma recurrences after liver transplantation.
Gerti DajtiGiuliana GerminarioEnrico ProsperiAntonio SiniscalchiFrancesco VasuriSabrina ValenteFederica OdaldiLorenzo MaroniMatteo SerenariValentina Rosa BertuzzoAndrea LaurenziMassimo Del GaudioMatteo CesconMatteo RavaioliPublished in: Artificial organs (2024)
Reducing cold ischemia time and graft perfusion with HOPE can lead to lower rates of early HCC recurrences and higher recurrence-free survival.